Demographic Influences on Adult HPV Vaccination: Results from a Cross-Sectional Survey in Tennessee

Author:

Cernasev Alina1,Oyedeji Oluwafemifola2,Springer Cary M.3ORCID,Hagemann Tracy M.1ORCID,Hohmeier Kenneth C.1ORCID,Kintziger Kristina W.4ORCID

Affiliation:

1. Department of Clinical Pharmacy and Translational Science, College of Pharmacy, University of Tennessee Health Science Center, 301 S. Perimeter Park Dr., Suite 220, Nashville, TN 37211, USA

2. Department of Public Health, University of Tennessee, Knoxville, 390 HPER, 1914 Andy Holt Ave., Knoxville, TN 37996, USA

3. Research Computing Support, Office of Innovative Technologies, University of Tennessee, Knoxville, 2309 Kingston Pike, Suite 132, Knoxville, TN 37996, USA

4. Department of Environmental, Agricultural & Occupational Health, College of Public Health, University of Nebraska Medical Center, Omaha, NE 68198, USA

Abstract

HPV is the most prevalent sexually transmitted infection in the U.S., with more than 80% of all Americans contracting it by age 45. Effective vaccines for HPV exist and were recently approved for adults aged 27–45 years, though uptake remains low in all age groups, particularly in Tennessee where 1089 cancers were attributed to HPV in 2020. Between 29 June and 17 August 2023, we conducted a cross-sectional survey to gain insights about the barriers and facilitators of HPV in 2011 adults aged 18 to 45 years in Tennessee. We developed our survey based on previous instruments to understand predictors of HPV vaccination in adults. Using descriptive statistics and bivariate and logistic regression analyses, we found higher vaccination rates in females, participants aged 18–38 years, participants with a high school education or higher, Hispanic or Latine individuals, and participants identifying as moderate or liberal. These insights highlight the need for public health interventions that consider demographic differences to successfully increase vaccination rates and reduce HPV-associated cancer risk.

Funder

Merck Sharp & Dohme Corp.

Publisher

MDPI AG

Reference38 articles.

1. Center for Disease Control and Prevention (2024, April 27). United States Cancer Statistics: Data Visualizations, Available online: https://gis.cdc.gov/Cancer/USCS/?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcancer%2Fdataviz%2Findex.htm#/RiskFactors/.

2. Center for Disease Control and Prevention (2024, March 12). HPV and Oropharyngeal Cancer, Available online: https://www.cdc.gov/cancer/hpv/basic_info/hpv_oropharyngeal.htm.

3. Oropharyngeal cancer incidence and mortality trends in all 50 states in the US, 2001–2017;Damgacioglu;JAMA Otolaryngol. Head Neck Surg.,2022

4. Recent trends in squamous cell carcinoma of the anus incidence and mortality in the United States, 2001–2015;Deshmukh;J. Natl. Cancer Inst.,2020

5. Gardasil: Introducing the new human papillomavirus vaccine;McLemore;Clin. J. Oncol. Nurs.,2006

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3